论文部分内容阅读
目的:探究参麦注射液联合不同类型他汀类药物治疗不稳定型心绞痛的近期疗效。方法:收集本院收治的不稳定型心绞痛患者37例,随机分成实验组与对照组。对照组18例予参麦注射液联合普伐他汀治疗;实验组19例予参麦注射液联合阿托伐他汀治疗。比较两组治疗前后血脂水平的变化及临床疗效。结果:治疗后,两组总胆固醇(TC)、低密度脂蛋白(LDL-C)水平均较治疗前显著下降(P<0.05),心绞痛发作次数及时间均明显减少或缩短(P<0.05);与对照组相比,实验组治疗后的TC、LDL-C水平均较低(P<0.05);不良反应发生率(15.8%)低于对照组(27.8%)(P<0.05)。结论:参麦注射液联合不同类型他汀类药物治疗不稳定型心绞痛的近期疗效相当,但阿托伐他汀治疗可更有效降低患者的血脂水平,安全性更高。
Objective: To investigate the short-term curative effect of Shenmai injection combined with different types of statins in the treatment of unstable angina pectoris. Methods: 37 patients with unstable angina pectoris admitted in our hospital were randomly divided into experimental group and control group. The control group of 18 cases of Shenmai injection combined with pravastatin treatment; experimental group 19 cases of Shenmai injection combined with atorvastatin treatment. The changes of blood lipid level and clinical efficacy before and after treatment were compared between the two groups. Results: The levels of total cholesterol (TC) and low density lipoprotein (LDL-C) in both groups were significantly decreased (P <0.05) and the number and time of angina pectoris were significantly decreased or shortened (P <0.05) (P <0.05). The incidence of adverse reactions (15.8%) was lower than that of the control group (27.8%) (P <0.05). Compared with the control group, the levels of TC and LDL-C in the experimental group were lower than those in the control group. Conclusion: Shenmai injection combined with different types of statins in the treatment of unstable angina pectoris has similar efficacy in the short term, but atorvastatin treatment can reduce the level of blood lipid in patients with higher safety.